Find NONOXYNOL-9 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

59 RELATED EXCIPIENT COMPANIES

102EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Nonoxynol 9, 14409-72-4, Delfen, Nonoxynol, n=9, 26571-11-9, Tergitol np-9
Molecular Formula
C33H60O10
Molecular Weight
616.8  g/mol
InChI Key
FBWNMEQMRUMQSO-UHFFFAOYSA-N

NONOXYNOL-9
Nonionic surfactant mixtures varying in the number of repeating ethoxy (oxy-1,2-ethanediyl) groups. They are used as detergents, emulsifiers, wetting agents, defoaming agents, etc. Nonoxynol-9, the compound with 9 repeating ethoxy groups, is a spermatocide, formulated primarily as a component of vaginal foams and creams.
1 2D Structure

NONOXYNOL-9

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[2-[2-[2-[2-[2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol
2.1.2 InChI
InChI=1S/C33H60O10/c1-2-3-4-5-6-7-8-9-32-10-12-33(13-11-32)43-31-30-42-29-28-41-27-26-40-25-24-39-23-22-38-21-20-37-19-18-36-17-16-35-15-14-34/h10-13,34H,2-9,14-31H2,1H3
2.1.3 InChI Key
FBWNMEQMRUMQSO-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCCCCCCCC1=CC=C(C=C1)OCCOCCOCCOCCOCCOCCOCCOCCOCCO
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Advantage S

2. Advantage-s

3. Delfen Cream

4. Delfen Creams

5. Emulgen 911

6. Emulgin 913

7. Nonoxinol

8. Nonoxinols

9. Nonoxynol

10. Nonoxynol 9

11. Nonoxynol, 1(4)-sulfate, Sodium Salt

12. Nonoxynol, 4-sulfate, Ammonium Salt

13. Nonoxynols

14. Nonylphenoxypolyethoxyethanol

15. Nonylphenoxypolyethoxyethanols

16. Oval, Patentex

17. Patentex Oval

2.2.2 Depositor-Supplied Synonyms

1. Nonoxynol 9

2. 14409-72-4

3. Delfen

4. Nonoxynol, N=9

5. 26571-11-9

6. Tergitol Np-9

7. Peg-9 Nonyl Phenyl Ether

8. Nonoxynol9

9. Tergitol Np9

10. Nonaethylene Glycol Nonylphenyl Ether

11. Nonylphenol Octa(oxyethylene) Ethanol

12. Nonaethylene Glycol Mono(nonylphenyl) Ether

13. Nonoxinol-9

14. 2-[2-[2-[2-[2-[2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol

15. Nonylphenoxypolyethoxyethanol

16. Polyoxyethylene (9) Nonyl Phenyl Ether

17. 26-(4-nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol

18. 26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol

19. Chebi:53775

20. Nsc-758941

21. P-nonylphenyl Polyethylene Glycol Ether

22. N-9

23. Conceptrol

24. Intercept

25. Semicid

26. 3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol, 26-(4-nonylphenoxy)-

27. 2-[2-[2-[2-[2-[2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]-ethoxy]ethoxy]ethoxy]ethoxy]ethanol

28. Staycept

29. Emko

30. Today Sponge

31. Nonoxinolum 9

32. Hsdb 8094

33. Gynol Ii

34. C-film

35. Norfox Np-9

36. Tergitol Tp-9

37. Nonoxynol-9.5

38. Einecs 247-816-5

39. Conco Ni-90

40. K-y Plus Nonoxynol-9

41. Spectrum2_001247

42. Spectrum3_001946

43. Alosetronhydrochloride

44. Chembl1410

45. Schembl36844

46. Bspbio_003546

47. Spectrum1505292

48. Spbio_001154

49. Dowfax 9n9, Neutronyx 611

50. Co-630sp

51. Kbio3_002833

52. Dtxsid00858720

53. Hms2093o22

54. Pharmakon1600-01505292

55. Zinc8214629

56. 3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol, 26-(nonylphenoxy)-

57. Bdbm50442874

58. Ccg-39124

59. Nsc758941

60. Akos015910808

61. Db06804

62. Nsc 758941

63. Ncgc00095907-02

64. Ncgc00095907-03

65. N 9

66. Sbi-0206761.p001

67. Polyethylene Glycol 450 Nonyl Phenyl Ether

68. Ab01563056_01

69. Q420039

70. Sr-05000001885

71. J-016227

72. Q-201490

73. Sr-05000001885-1

74. Brd-k88625236-001-01-8

75. 1-(4-nonylphenyl)-1,4,7,10,13,16,19,22,25-nonaoxaheptacosan-27-ol

76. N9

2.3 Create Date
2005-08-01
3 Chemical and Physical Properties
Molecular Weight 616.8 g/mol
Molecular Formula C33H60O10
XLogP34.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count10
Rotatable Bond Count35
Exact Mass616.41864811 g/mol
Monoisotopic Mass616.41864811 g/mol
Topological Polar Surface Area103 Ų
Heavy Atom Count43
Formal Charge0
Complexity520
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameToday
PubMed HealthNonoxynol 9 (Vaginal)
Drug ClassesContraceptive, Local
Active IngredientNonoxynol-9
Dosage FormSponge
RouteVaginal
Strength1gm
Market StatusOver the Counter
CompanyMayer Labs

2 of 2  
Drug NameToday
PubMed HealthNonoxynol 9 (Vaginal)
Drug ClassesContraceptive, Local
Active IngredientNonoxynol-9
Dosage FormSponge
RouteVaginal
Strength1gm
Market StatusOver the Counter
CompanyMayer Labs

4.2 Drug Warning

In January, 2003, FDA proposed new warning statements and other labeling information for these products after results from a major clinical study in Africa and Thailand showed that women using a contraceptive gel product containing N9 were not protected against HIV and other STDs and were, in fact, at higher risk for HIV infection than women using a placebo gel. Because these and other studies have shown that use of products containing N9 cause vaginal and rectal irritation that can heighten the chance of becoming infected with HIV from an infected partner, FDA believes the warning will empower consumers to make better informed decisions about the use of these products, and better protect the public health.

DHHS/FDA; For Consumers: New Warning for Nonoxynol 9 OTC Contraceptive Products re: STDS and HIV/AIDS (June18, 2009). Available from, as of October 16, 2012: https://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm124023.htm


The FDA issued a final rule on December 18, 2007 requiring manufacturers of over-the-counter (OTC) stand-alone vaginal contraceptive and spermicidal products containing the chemical ingredient nonoxynol 9 (N9) include a warning stating that the chemical N9 does not provide protection against infection from HIV (the virus that causes AIDS) or other sexually transmitted diseases (STDs). Stand-alone spermicides include gels, foams, films, or inserts containing N9 that are used by themselves for contraception. Consumers can protect themselves from the transmission of STDs and HIV by practicing abstinence, being in a monogamous relationship where neither partner is infected, and using condoms consistently and correctly. FDA is issuing the rule in an effort to correct misconceptions that N9 protects against sexually transmitted diseases, including HIV infection.

DHHS/FDA; For Consumers: New Warning for Nonoxynol 9 OTC Contraceptive Products re: STDS and HIV/AIDS (June18, 2009). Available from, as of October 16, 2012: https://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm124023.htm


Sexually transmitted diseases (STDs) alert: This product does not protect against HIV/AIDS or other STDs and may increase the risk of getting HIV from an infected partner.

DHHS/FDA; For Consumers: New Warning for Nonoxynol 9 OTC Contraceptive Products re: STDS and HIV/AIDS (June18, 2009). Available from, as of October 16, 2012: https://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm124023.htm


Do not use if you or your sex partner has HIV/AIDS. If you do not know if you or your sex partner is infected, choose another form of birth control.

DHHS/FDA; For Consumers: New Warning for Nonoxynol 9 OTC Contraceptive Products re: STDS and HIV/AIDS (June18, 2009). Available from, as of October 16, 2012: https://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm124023.htm


For more Drug Warnings (Complete) data for Nonoxynol-9 (7 total), please visit the HSDB record page.


4.3 Drug Indication

Nonoxynol 9 is a surfactant spermicide used for contraception in spermicidal creams, jellies, foams, gel, and lubricants. It is also used in conjuction with other methods of contraception, including condoms, cervical caps and diaphragms.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Surface-Active Agents

Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)


Spermatocidal Agents

Chemical substances that are destructive to spermatozoa used as topically administered vaginal contraceptives. (See all compounds classified as Spermatocidal Agents.)


5.2 Absorption, Distribution and Excretion

In mice intravenously injected with (14)C-Nonoxynol-9, the highest amounts of radioactivity were reported for the small and large intestines. (14)C radioactivity was excreted mainly in the urine and feces. An HPLC analysis of the urine and bile indicated that no intact Nonoxynol-9 was present in the bile or urine, and that Nonoxynol-9 was metabolized to highly polar species.

Alan AF ed.; Cosmetic Ingredient Review: Amended final report on the safety assessment of Nonoxynol -1, -2, -3, -4, -5, -6, -7 and -8. Int J Toxicol 18 (Suppl 1):11-31 (1999)


In in vitro skin penetration studies using cadaver skin (rinse off and leave-on protocols), the total skin penetration of Nonoxynol-2, -4, and -9 was less than 1 % over a period of 48 hours.

Alan AF ed.; Cosmetic Ingredient Review: Amended final report on the safety assessment of Nonoxynol -1, -2, -3, -4, -5, -6, -7 and -8. Int J Toxicol 18 (Suppl 1):11-31 (1999)


The disposition of nonoxynol-9 labeled with (14)C at the ethylene oxide units was studied following an iv or vaginal administration to female Sprague-Dawley rats. The results from the vaginal administration studies indicate 12.8% absorption of (14)C radioactivity in 6.0 hr and 37.7% in 24.0 hr. Tissue distribution studies showed that the small and large intestines, including their contents, had the highest (14)C activity by either route of administration. Radiomonitored HPLC of bile collected at 6.0 hr and urine at 6.0, 24.0, and 48.0 hr following an iv injection of (14)C nonoxynol-9 showed that the compound was completely metabolized in the body of the rat. The metabolites were primarily excreted in the feces and secondarily in the urine. Analysis of urinary metabolites containing the (14)C label, 6.0 hr following an iv dose, indicated the presence of highly polar neutral (53.27%) and acidic (39.23%) species.

PMID:2848334 Walter BA et al; Toxicol Appl Pharmacol 96 (2): 258-68 (1988)


5.3 Mechanism of Action

Nonoxynol-9 interacts with the lipids in the membranes of the acrosome and the midpiece of the sperm. The sperm membranes are lysed; the acrosome, neck and midpiece of the spermatozoa are loosened and then detached which results in their immobilization and death.


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

Solvay Usa Inc

Belgium

USDMF

arrow
Pharmatech Expo 2025
Not Confirmed

01

Solvay Usa Inc

Belgium
arrow
Pharmatech Expo 2025
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 339

Submission : 1959-07-08

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Pharmatech Expo 2025
Not Confirmed
arrow
arrow
Pharmatech Expo 2025
Not Confirmed

NONOXYNOL-9

About the Company : Hefei TNJ Chemical Industry, established in 2001, is a key chemical manufacturer and supplier in China. In 2001, three young chemists from a local large state-owned chemical facto...

Hefei TNJ Chemical Industry, established in 2001, is a key chemical manufacturer and supplier in China. In 2001, three young chemists from a local large state-owned chemical factory established TNJ Chemical by starting from producing PVP products. By taking advantage of technology innovation, TNJ made fast and steady development in PVP. Meanwhile, in order to further enhance comprehensive competence, TNJ begun to seek for products diversity and invested more chemical lines to meet market demands. Up to 2015, TNJ owns key products of more than 60 which covers four fields: Chemicals, Food, Pharmaceutical and Personal care.
blank

02

Pharmatech Expo 2025
Not Confirmed
arrow
arrow
Pharmatech Expo 2025
Not Confirmed

NONOXYNOL-9

About the Company : Ocean Pharmacoat Pvt Ltd and KRS Pharmaceuticals Pvt Ltd are one of the leading manufacturer of Pharmaceuticals Pellets, Activ pharmaceutical Ingrediants and its intermediates and ...

Ocean Pharmacoat Pvt Ltd and KRS Pharmaceuticals Pvt Ltd are one of the leading manufacturer of Pharmaceuticals Pellets, Activ pharmaceutical Ingrediants and its intermediates and Company established in year 2000. Mr. B. Narendra as the Manging Director and Mr. B. L. Swamy as the Director of the company. We operate the manufacturing capacity of 1400 MT per annum for Pharmaceutical Pellets and 216 KL capacity of the reactors for APIs and its intermediates.The company engaed with Manufacturing of Pharmaceutical Pellets and ISO-9001-2008 and WHO-GMP certified vertically integrated active pharmaceutical ingrediaent pellets manufacturing company meeting cGMP standards.
blank

03

Pharmatech Expo 2025
Not Confirmed
arrow
arrow
Pharmatech Expo 2025
Not Confirmed

NONOXYNOL-9

About the Company : "SimSon Pharma, a renowned name in pharmaceutical sector, has build high its reputation as a complete solution provider in contract research arena. We are leading manufacturer and ...

"SimSon Pharma, a renowned name in pharmaceutical sector, has build high its reputation as a complete solution provider in contract research arena. We are leading manufacturer and supplier of pharmaceutical Reference materials like Drug working standard, Drug impurity standards, Drug metabolites and Stable Isotope Labelled compounds. Our expertise in this area has made us one of the the most trusted companies in the industry. We are the front runner in manufacturing complicated Drug impurity standards or Reference materials and the complete solution provider in identifying, synthesizing and qualifying any Unknown impurity. We have scaled up our operations to make the company a holistic solution provider and would be supplying all reference chemicals and materials for research requirements . In short, we are one stop solutions for Chemical development, Formulation development, Analytical development and Regulatory services. SimSon Pharma not only synthesize and supply molecules but also provides cost effective & innovative approach to help companies achieve success. We work closely with our clients for understanding their requirements and offer them time bound solutions. Vision: To become a leading pharma company and a preferred partner for the global pharma industry for Reference materials, Research chemicals and R&D services. Mission: We strive to provide a cost-effective and time-bound research solutions in the area of custom synthesis, formulation development and analytical development."
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1701714600,"product":"PHARMACEUTICAL RAW MATERIAL BULK DRUGS :NONOXYNOL-9 USP","address":"112,, MARINE CHAMBERS,","city":"MUMBAI. MAHARASHTRA","supplier":"ALCON BIOSCIENCES","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"TO ORDER.,","customerCountry":"EGYPT","quantity":"15.00","actualQuantity":"15","unit":"KGS","unitRateFc":"280","totalValueFC":"4144.5","currency":"USD","unitRateINR":23000,"date":"05-Dec-2023","totalValueINR":"345000","totalValueInUsd":"4144.5","indian_port":"Bombay Air","hs_no":"29333990","bill_no":"5822439","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"112,, MARINE CHAMBERS,, MUMBAI. MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1717957800,"product":"PHARMA. RAW MATERIAL-BULK DRUG\/EXCIPIENTS\/FOR PHARMACEUTICAL INDU: NONOXYNOL-9","address":"708, TIMES SQUARE ARCADE,","city":"AHMEDABAD","supplier":"SKJ HEALTHCARE PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"DAMASCUS (DAMAS)","customer":"TO THE ORDER OF BEIRUT","customerCountry":"SYRIA","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"300","totalValueFC":"7159.3","currency":"USD","unitRateINR":23906.333199999997,"date":"10-Jun-2024","totalValueINR":"597658.33","totalValueInUsd":"7159.3","indian_port":"Ahmedabad ICD","hs_no":"29333990","bill_no":"1556047","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SYRIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad ICD","supplierAddress":"708, TIMES SQUARE ARCADE,, AHMEDABAD","customerAddress":""}]
05-Dec-2023
10-Jun-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

FDF Dossiers

read-more
read-more

01

Mayer Labs

U.S.A
Pharma, Lab & Chemical Expo
Not Confirmed
arrow

Mayer Labs

U.S.A
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

NONOXYNOL-9

Brand Name : TODAY

Dosage Form : SPONGE;VAGINAL

Dosage Strength : 1GM

Packaging :

Approval Date : 1983-04-01

Application Number : 18683

Regulatory Info : DISCN

Registration Country : USA

blank

02

Pharma, Lab & Chemical Expo
Not Confirmed
arrow
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

NONOXYNOL-9

Brand Name : DELFEN

Dosage Form : AEROSOL;VAGINAL

Dosage Strength : 12.5%

Packaging :

Approval Date : 1982-01-01

Application Number : 14349

Regulatory Info : DISCN

Registration Country : USA

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

Pharmatech Expo 2025
Not Confirmed
arrow
arrow
Pharmatech Expo 2025
Not Confirmed

NONOXYNOL-9

Brand Name : TODAY

Dosage Form : SPONGE;VAGINAL

Dosage Strength : 1GM

Approval Date : 1983-04-01

Application Number : 18683

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

02

PERSONAL PRODS

Germany
Pharmatech Expo 2025
Not Confirmed
arrow

PERSONAL PRODS

Germany
arrow
Pharmatech Expo 2025
Not Confirmed

NONOXYNOL-9

Brand Name : DELFEN

Dosage Form : AEROSOL;VAGINAL

Dosage Strength : 12.5%

Approval Date : 1982-01-01

Application Number : 14349

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more
click full view

Film Formers & Plasticizers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Grade : Oral

Category : Taste Masking

02

SPI Pharma

U.S.A
arrow
Duphat
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

Grade : Oral

Category : Film Formers & Plasticizers

03

arrow
Duphat
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

Category : Film Formers & Plasticizers

04

arrow
Duphat
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

07

arrow
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

ASK US

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

08

arrow
Duphat
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Oral

Category : Film Formers & Plasticizers

click full view

Fillers, Diluents & Binders

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Solubilizers

read-more
read-more

Topical

read-more
read-more

Parenteral

read-more
read-more

Controlled & Modified Release

read-more
read-more

Rheology Modifiers

read-more
read-more

Taste Masking

read-more
read-more

Co-Processed Excipients

read-more
read-more

API Stability Enhancers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Lubricants & Glidants

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Soft Gelatin

read-more
read-more

Emulsifying Agents

read-more
read-more

Direct Compression

read-more
read-more

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
PharmaCompass
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Nonoxynol 9 Manufacturers

A Nonoxynol 9 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nonoxynol 9, including repackagers and relabelers. The FDA regulates Nonoxynol 9 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nonoxynol 9 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Nonoxynol 9 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Nonoxynol 9 Suppliers

A Nonoxynol 9 supplier is an individual or a company that provides Nonoxynol 9 active pharmaceutical ingredient (API) or Nonoxynol 9 finished formulations upon request. The Nonoxynol 9 suppliers may include Nonoxynol 9 API manufacturers, exporters, distributors and traders.

click here to find a list of Nonoxynol 9 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Nonoxynol 9 USDMF

A Nonoxynol 9 DMF (Drug Master File) is a document detailing the whole manufacturing process of Nonoxynol 9 active pharmaceutical ingredient (API) in detail. Different forms of Nonoxynol 9 DMFs exist exist since differing nations have different regulations, such as Nonoxynol 9 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Nonoxynol 9 DMF submitted to regulatory agencies in the US is known as a USDMF. Nonoxynol 9 USDMF includes data on Nonoxynol 9's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nonoxynol 9 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Nonoxynol 9 suppliers with USDMF on PharmaCompass.

Nonoxynol 9 CEP

A Nonoxynol 9 CEP of the European Pharmacopoeia monograph is often referred to as a Nonoxynol 9 Certificate of Suitability (COS). The purpose of a Nonoxynol 9 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Nonoxynol 9 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Nonoxynol 9 to their clients by showing that a Nonoxynol 9 CEP has been issued for it. The manufacturer submits a Nonoxynol 9 CEP (COS) as part of the market authorization procedure, and it takes on the role of a Nonoxynol 9 CEP holder for the record. Additionally, the data presented in the Nonoxynol 9 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Nonoxynol 9 DMF.

A Nonoxynol 9 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Nonoxynol 9 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Nonoxynol 9 suppliers with CEP (COS) on PharmaCompass.

Nonoxynol 9 GMP

Nonoxynol 9 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Nonoxynol 9 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nonoxynol 9 GMP manufacturer or Nonoxynol 9 GMP API supplier for your needs.

Nonoxynol 9 CoA

A Nonoxynol 9 CoA (Certificate of Analysis) is a formal document that attests to Nonoxynol 9's compliance with Nonoxynol 9 specifications and serves as a tool for batch-level quality control.

Nonoxynol 9 CoA mostly includes findings from lab analyses of a specific batch. For each Nonoxynol 9 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Nonoxynol 9 may be tested according to a variety of international standards, such as European Pharmacopoeia (Nonoxynol 9 EP), Nonoxynol 9 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nonoxynol 9 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty